Glaucoma Awareness Month is celebrated in the USA in January. The green ribbon is waving. Healthcare vector illustration banner for web.

Two Compelling Cases of Significant IOP Reduction in Advanced Glaucoma

Recent breakthroughs in minimally invasive glaucoma treatment are reshaping the approach to managing this disease. One standout innovation, the iStent Infinite, demonstrates remarkable potential in improving patients’ outflow pathways without resorting to more invasive procedures.

Davinder S. Grover, MD, MPH, of Glaucoma Associates of Texas, has incorporated the iStent Infinite into his surgical approach, either as a standalone procedure or in conjunction with cataract surgery. Based on his firsthand experience with the device, Dr. Grover has observed outstanding outcomes.

He often opts for this surgery due to its minimally invasive nature and the favorable likelihood of success. Dr. Grover expressed his goal, stating, “My hope is to optimize the natural outflow pathway of their eyes without the need for creating a new one.” He emphasizes that placing 3 stents, a distinctive feature of the iStent infinite, spaced 2-3 clock hours apart from each other in the nasal angle, can significantly enhance a patient’s outflow pathway, even in advanced to refractory cases.

Read more:https://ophthalmology360.com/glaucoma/two-compelling-cases-of-significant-iop-reduction-in-advanced-glaucoma/

Source: OPHTHALMOLOGY 360